Adagio Medical Holdings, Inc. (ADGM)
ADGM Stock Price Chart
Explore Adagio Medical Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ADGM price movements and trends.
ADGM Company Profile
Discover essential business fundamentals and corporate details for Adagio Medical Holdings, Inc. (ADGM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
23 Jul 2024
Employees
80.00
Website
https://adagiomedical.comCEO
Todd Usen
Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
ADGM Financial Timeline
Browse a chronological timeline of Adagio Medical Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Aug 2025
EPS came in at -$0.35 .
Earnings released on 15 May 2025
EPS came in at -$0.50 .
ADGM Stock Performance
Access detailed ADGM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.